Sword Health Raises $163M And Reaches $2B Valuation As The Fastest Growing Digital Msk Company
11/22/21, 7:47 AM
Money raised
$163 million
SWORD Health, the most clinical and comprehensive digital musculoskeletal (MSK) solution in the market, today announced its Series D funding round led by Sapphire Ventures, a leading global technology-focused venture capital firm with participation from new investors Sozo Ventures, Willoughby Capital, ADQ and Localglobe, and from all major investors including General Catalyst, Khosla Ventures, Founders Fund, Bond, Transformation Capital, and Green Innovations. This brings the total primary and secondary transactions to more than $320M invested in SWORD, with the current round valued at $1.8B, catapulting it to healthtech unicorn status. The primary funding round of $163M was heavily oversubscribed, resulting in investors purchasing an additional $26M, in a secondary transaction which propelled the valuation to $2B.
Company Info
Additional Info
“Through our market and customer work, we found that SWORD is providing tangible clinical outcomes to drive healthier, happier lives for individuals, and meaningful cost-savings for customers – a winning approach. The round will enable SWORD to accelerate its mission to free two billion people from physical pain through more personalized MSK based offerings - from prevention to post-surgical care - while still remaining at the forefront of value-based digital MSK care and expanding local and global operations among self-insured employers, health plans and other entities. “I started SWORD after a traumatic personal experience where I saw first-hand the challenges that families face when they have to recover a loved one,” shared Virgilio Bento, founder and CEO of SWORD Health. “It’s been truly humbling to see the impact SWORD is having on thousands of members across the globe.